Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;30(15):1157-1166.
doi: 10.2174/0113816128300061240319034243.

CASC19: An Oncogenic Long Non-coding RNA in Different Cancers

Yinxin Wu  1   2   3 , Jie Mou  1   2   3 , Gang Zhou  4   5 , Chengfu Yuan  1   2   3
Affiliations
Review

CASC19: An Oncogenic Long Non-coding RNA in Different Cancers

Yinxin Wu et al. Curr Pharm Des. 2024.

Abstract

A 324 bp lncRNA called CASC19 is found on chromosome 8q24.21. Recent research works have revealed that CASC19 is involved in the prognosis of tumors and related to the regulation of the radiation tolerance mechanisms during tumor radiotherapy (RT). This review sheds light on the changes and roles that CASC19 plays in many tumors and diseases, such as nasopharyngeal carcinoma (NPC), cervical cancer, colorectal cancer (CRC), non-small cell lung cancer (NSCLC), clear cell renal cell carcinoma (ccRCC), gastric cancer (GC), pancreatic cancer (PC), hepatocellular carcinoma (HCC), glioma, and osteoarthritis (OA). CASC19 provides a new strategy for targeted therapy, and the regulatory networks of CASC19 expression levels play a key role in the occurrence and development of tumors and diseases. In addition, the expression level of CASC19 has predictive roles in the prognosis of some tumors and diseases, which has major implications for clinical diagnoses and treatments. CASC19 is also unique in that it is a key gene affecting the efficacy of RT in many tumors, and its expression level plays a decisive role in improving the success rate of treatments. Further research is required to determine the precise process by which CASC19 causes changes in diseased cells in some tumors and diseases.

Keywords: CASC19; LncRNA; biomarkers; gastric cancer.; radiation resistance; tumors.

PubMed Disclaimer

References

    1. Kopp F.; Mendell J.T.; Functional classification and experimental dissection of long noncoding RNAs. Cell 2018,172(3),393-407 - DOI - PubMed
    1. Bartonicek N.; Maag J.L.V.; Dinger M.E.; Long noncoding RNAs in cancer: Mechanisms of action and technological advancements. Mol Cancer 2016,15(1),43 - DOI - PubMed
    1. Xiao J.N.; Yan T.H.; Yu R.M.; Gao Y.; Zeng W.L.; Lu S.W.; Que H.X.; Liu Z.P.; Jiang J.H.; Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. J Cancer Res Clin Oncol 2017,143(6),981-990 - DOI - PubMed
    1. Kalmár A.; Nagy Z.B.; Galamb O.; Csabai I.; Bodor A.; Wichmann B.; Valcz G.; Barták B.K.; Tulassay Z.; Igaz P.; Molnár B.; Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition. BMC Cancer 2019,19(1),1059 - DOI - PubMed
    1. Wang Y.; Chen W.; Lian J.; Zhang H.; Yu B.; Zhang M.; Wei F.; Wu J.; Jiang J.; Jia Y.; Mo F.; zhang S.; Liang X.; Mou X.; Tang J.; The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell Death Differ 2020,27(2),695-710 - DOI - PubMed

Substances